Clinical Trial

Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this registry is to collect information on how the Zenflow Spring System works in everyday medical practice. The registry will track how the Spring System performs during the implant procedure, and at follow-up visits at 1, 3, 6, and 12 months. We will look at how symptoms improve, how quickly patients return to normal activities, how satisfied they are with treatment, and whether there are any problems or side effects related to the device.
Protocol Amendment History 2 changes
notable Trial sites expanded: 2 -> 5 locations 2026-07-22
notable Primary completion pushed: 2028-06 -> 2028-07 2026-07-22
Trial Details
NCT Number NCT07538622
Lead Sponsor Zenflow, Inc.
Conditions BPH (Benign Prostatic Hyperplasia)
Enrollment 300 participants
Start Date 2026-07
Primary Completion 2028-07 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-21